DP

Diadema Partners Portfolio holdings

AUM $161M
This Quarter Return
+0.4%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
Cap. Flow
+$39.8M
Cap. Flow %
24.76%
Top 10 Hldgs %
70.2%
Holding
94
New
17
Increased
16
Reduced
11
Closed
14

Top Buys

1
SLNO icon
Soleno Therapeutics
SLNO
$16M
2
AMGN icon
Amgen
AMGN
$14.5M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$7.7M
4
TGTX icon
TG Therapeutics
TGTX
$5.89M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
$4.45M

Top Sells

1
REGN icon
Regeneron Pharmaceuticals
REGN
$12.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
$3.54M
3
LLY icon
Eli Lilly
LLY
$3.5M
4
ARGX icon
argenx
ARGX
$3.48M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
$2.65M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NVO icon
76
Novo Nordisk
NVO
$253B
– –
-24,618
Closed -$1.68M
OCUL icon
77
Ocular Therapeutix
OCUL
$2.22B
– –
0
– –
PFE icon
78
Pfizer
PFE
$142B
– –
0
– –
PRTA icon
79
Prothena Corp
PRTA
$452M
– –
0
– –
QURE icon
80
uniQure
QURE
$962M
– –
-36,500
Closed -$387K
RXRX icon
81
Recursion Pharmaceuticals
RXRX
$2.1B
– –
0
– –
RYTM icon
82
Rhythm Pharmaceuticals
RYTM
$6.94B
– –
-50,000
Closed -$2.65M
SAGE
83
DELISTED
Sage Therapeutics
SAGE
– –
-183,466
Closed -$1.46M
SAVA icon
84
Cassava Sciences
SAVA
$111M
– –
0
– –
SGMT icon
85
Sagimet Biosciences
SGMT
$245M
– –
-46,019
Closed -$150K
SLS icon
86
SELLAS Life Sciences
SLS
$190M
– –
0
– –
SPRY icon
87
ARS Pharmaceuticals
SPRY
$1.09B
– –
0
– –
SWTX
88
DELISTED
SpringWorks Therapeutics
SWTX
– –
-60,000
Closed -$2.65M
TNGX icon
89
Tango Therapeutics
TNGX
$752M
– –
0
– –
UBX
90
DELISTED
Unity Biotechnology
UBX
– –
0
– –
VERV
91
DELISTED
Verve Therapeutics
VERV
– –
0
– –
XBI icon
92
SPDR S&P Biotech ETF
XBI
$5.35B
– –
0
– –
ZYME icon
93
Zymeworks
ZYME
$1.07B
– –
0
– –
ATYR
94
aTyr Pharma
ATYR
$561M
– –
0
– –
1 2 3
4